+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Network Point-of-Care Glucose Testing Market Size, Share & Trends Analysis Report By Product (i-STAT, Accu-Chek Inform II, StatStrip, HemoCue, CareSens Expert Plus, BAROzen H Expert Plus), By Region, And Segment Forecasts, 2021 - 2028

  • ID: 5440491
  • Report
  • September 2021
  • Region: Global
  • 90 Pages
  • Grand View Research

FEATURED COMPANIES

  • Abbott
  • Danaher
  • F. Hoffmann-La Roche Ltd.
  • Nova Biomedical
The global network point-of-care glucose testing market size is expected to reach USD 1.6 billion by 2028, according to a new report by the publisher. It is expected to expand at a CAGR of 3.9% from 2021 to 2028. Increasing demand for safe and accurate remote patient monitoring options and the need for data-based treatment regimens are major factors driving the market. The integration of advanced technologies including Bluetooth Low Energy (BLE) and Infrared is expected to fuel the market growth in the upcoming years.



Expanding patient base in Asia Pacific and the Middle East and the high demand for advanced diabetes management systems are creating significant growth opportunities in these regions. These regions also include some of the highly preferred destinations for medical tourism. Increasing demand for world-class healthcare services and rising adoption of advanced technology are some of the factors boosting the market growth in these regions.

Network point-of-care glucose meters were extensively used in COVID-19 care. This enabled doctors to remotely observe glucose levels with minimal risk of infection. In addition, a large amount of data is still being used to customize treatment plans for diabetic COVID-19 patients. Preference for telemedicine and trends of home healthcare settings for chronic patients are some of the factors expected to expand the applications of network-based point-of-care devices.

Network Point-of-Care Glucose Testing Market Report Highlights

  • Network point-of-care devices were in high demand during the first and second wave of COVID-19 owing to their advantage of remote patient monitoring
  • Based on product, the Accu-Chek Inform II segment held the largest revenue share in 2020 and is expected to expand at a lucrative growth rate during the forecast period
  • North America held the largest revenue share in 2020 and is predicted to maintain its lead over the forecast period owing to the factors such as the presence of major players and high adoption rate
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • Danaher
  • F. Hoffmann-La Roche Ltd.
  • Nova Biomedical
Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Product
1.1.2 Regional Scope
1.1.3 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.3.5.1 Data for primary interviews in North America
1.3.5.3 Data for Primary Interviews in Europe
1.3.5.4 Data for Primary Interviews in APAC
1.3.5.6 Data for Primary Interviews in Latin America
1.3.5.8 Data for Primary Interviews in MEA
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 Objectives
1.8.1 Objective 1:
1.8.2 Objective 2:

Chapter 2 Executive Summary
2.1 Market Outlook

Chapter 3 Market Variables, Trends & Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.1.1 Introduction of CLIA waived tests
3.1.1.2 Untapped opportunities in the developing economies
3.1.1.3 Rising demand for short turnaround time glucose POC testing
3.1.1.4 Growing focus on diabetes care
3.1.2 Market Restraint Analysis
3.1.2.1 Potential interference and calibration issues in glucose meters
3.1.2.2 Presence of ambiguous regulatory as well as reimbursement framework
3.2 Network Point-of-Care Glucose Testing Market Analysis Tools
3.2.1 Industry Analysis - Porter’s
3.2.2 PESTEL Analysis
3.2.3 Reimbursement Scenario
3.2.4 Market Share Analysis, By Product, 2020 (%)
3.2.5 Market Share Analysis, By Region, 2020 (%)
3.2.6 Pricing Analysis
3.2.6.1 North America
3.2.6.2 Europe
3.2.6.3 Asia Pacific
3.2.6.4 Latin America
3.2.6.5 Middle East and Africa

Chapter 4 Network Point-of-Care Glucose Testing: Product Estimates & Trend Analysis
4.1 Definitions and Scope
4.2 Product Market Share Analysis
4.3 Segment Dashboard
4.4 Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
4.5 i-STAT
4.5.1 i-STAT Market Estimates And Forecast, 2016 - 2028
4.6 Accu-Chek Inform II
4.6.1 Accu-Chek Inform II Estimates And Forecast, 2016 - 2028
4.7 StatStrip
4.7.1 StatStrip Market Estimates And Forecast, 2016 - 2028
4.8 HemoCue
4.8.1 HemoCue Market Estimates And Forecast, 2016 - 2028
4.9 CareSens Expert Plus
4.9.1 CareSens Expert Plus Market Estimates And Forecast, 2016 - 2028
4.10 BAROzen H Expert Plus
4.10.1 BAROzen H Expert Plus Market Estimates And Forecast, 2016 - 2028

Chapter 5 Network Point-of-care Glucose Testing Market: Regional Market Analysis, 2016 - 2028 (Value) (USD Million)
5.1 Regional market share analysis, 2020 & 2028
5.2 North America
5.2.1 North America Network Point-of-care glucose testing market, 2016 - 2028 (USD Million)
5.2.2 U.S.
5.2.2.1 U.S. Network Point-of-care glucose testing market, 2016 - 2028 (USD Million)
5.2.3 Canada
5.2.3.1 Canada Network Point-of-care glucose testing market, 2016 - 2028 (USD Million)
5.3 Europe
5.3.1 Europe Network Point-of-care glucose testing market, 2016 - 2028 (USD Million)
5.3.2 U.K.
5.3.2.1 U.K. Network point-of-care glucose testing market, 2016 - 2028 (USD Million)
5.3.3 Germany
5.3.3.1 Germany Network point-of-care glucose testing market, 2016 - 2028 (USD Million)
5.3.4 France
5.3.4.1 France Network point-of-care glucose testing market, 2016 - 2028 (USD Million)
5.3.5 Italy
5.3.5.1 Italy network point-of-care glucose testing market, 2016 - 2028 (USD Million)
5.3.6 Spain
5.3.6.1 Spain Network point-of-care glucose testing market, 2016 - 2028 (USD Million)
5.3.7 Russia
5.3.7.1 Russia Network point-of-care glucose testing market, 2016 - 2028 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific Network point-of-care glucose testing market, 2016 - 2028 (USD Million)
5.4.2 Japan
5.4.2.1 Japan Network point-of-care glucose testing market, 2016 - 2028 (USD Million)
5.4.3 China
5.4.3.1 China Network point-of-care glucose testing market, 2016 - 2028 (USD Million)
5.4.4 India
5.4.4.1 India Network point-of-care glucose testing market, 2016 - 2028 (USD Million)
5.4.5 Australia
5.4.5.1 Australia network point-of-care glucose testing market, 2016 - 2028 (USD Million)
5.4.6 South Korea
5.4.6.1 South Korea network point-of-care glucose testing market, 2016 - 2028 (USD Million)
5.4.7 Thailand
5.4.7.1 Thailand Network point-of-care glucose testing market, 2016 - 2028 (USD Million)
5.5 Latin America
5.5.1 Latin America network point-of-care glucose testing market, 2016 - 2028 (USD Million)
5.5.2 Brazil
5.5.2.1 Brazil network point-of-care glucose testing market, 2016 - 2028 (USD Million)
5.5.3 Mexico
5.5.3.1 Mexico Network point-of-care glucose testing market, 2016 - 2028 (USD Million)
5.5.4 Argentina
5.5.4.1 Argentina network point-of-care glucose testing market, 2016 - 2028 (USD Million)
5.5.5 Colombia
5.5.5.1 Colombia network point-of-care glucose testing market, 2016 - 2028 (USD Million)
5.6 MEA
5.6.1 MEA Network point-of-care glucose testing market, 2016 - 2028 (USD Million)
5.6.2 South Africa
5.6.2.1 South Africa Network point-of-care glucose testing market, 2016 - 2028 (USD Million)
5.6.3 Saudi Arabia
5.6.3.1 Saudi Arabia Network point-of-care glucose testing market, 2016 - 2028 (USD Million)
5.6.4 UAE
5.6.4.1 UAE Network point-of-care glucose testing market, 2016 - 2028 (USD Million)

Chapter 6 Competitive Landscape
6.1 Company profiles
6.1.1 F. Hoffmann-La Roche Ltd.
6.1.1.1 Company Overview
6.1.1.2 Financial performance
6.1.1.3 Product Benchmarking
6.1.2 Abbott
6.1.2.1 Company Overview
6.1.2.2 Financial performance
6.1.2.3 Product Benchmarking
6.1.2.4 Recent Developments
6.1.3 Nova Biomedical
6.1.3.1 Company Overview
6.1.3.2 Product Benchmarking
6.1.3.3 Recent Developments
6.1.4 Bayer AG/Ascensia Diabetes Care Holdings AG
6.1.4.1 Company Overview
6.1.4.2 Financial Performance
6.1.4.3 Product Benchmarking
6.1.5 Danaher
6.1.5.1 Company Overview
6.1.5.2 Financial performance
6.1.5.3 Product Benchmarking
6.1.5.4 Recent Developments

List of Tables

Table 1 Market research process
Table 2 Data triangulation techniques
Table 3 Primary research pattern
Table 4 Primary interviews in North America
Table 5 Primary interviews in Europe
Table 6 Primary interviews in APAC
Table 7 Primary interviews in Latin America
Table 8 Primary interviews in MEA
Table 9 Market research approaches
Table 10 Value-chain-based sizing & forecasting
Table 11 QFD modeling for market share assessment
Table 12 Market formulation & validation
Table 13 Network Point-of-Care Glucose Testing Market: Market Outlook (USD Mn), 2020
Table 14 Shift in POC molecular diagnostic trends
Table 15 Schematic representation of POC testing device connectivity
Table 16 Porter’s five forces analysis
Table 17 SWOT analysis, by factor (political & legal, economic and technological)
Table 18 Network point-of-care glucose testing market: Product movement analysis
Table 19 Network Point-of-care glucose testing market: Product outlook and key takeaways
Table 20 i-STAT market estimates and forecast, 2016 - 2028
Table 21 Accu-Chek Inform II market estimates and forecast, 2016 - 2028
Table 22 StatStrip market estimates and forecast, 2016 - 2028
Table 23 HemoCue market estimates and forecast, 2016 - 2028
Table 24 CareSens Expert Plus market estimates and forecast, 2016 - 2028
Table 25 BAROzen H Expert Plus market estimates and forecast, 2016 - 2028
Table 26 Network global point-of-care glucose testing market: Regional movement analysis
Table 27 North America network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 28 U.S. network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 29 Canada network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 30 Europe network point-of-care) glucose testing market, 2016 - 2028 (USD Million)
Table 31 U.K. network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 32 Germany network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 33 France network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 34 Italy network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 35 Spain network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 36 Russia network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 37 Asia Pacific network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 38 Japan network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 39 China network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 40 India network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 41 Australia network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 42 South Korea network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 43 Thailand network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 44 Latin America network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 45 Brazil network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 46 Mexico network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 47 Argentina network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 48 Colombia network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 49 MEA network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 50 South Africa network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 51 Saudi Arabia network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 52 UAE network point-of-care glucose testing market, 2016 - 2028 (USD Million)

List of Figures

Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Primary interviews in North America
Figure 5 Primary interviews in Europe
Figure 6 Primary interviews in APAC
Figure 7 Primary interviews in Latin America
Figure 8 Primary interviews in MEA
Figure 9 Market research approaches
Figure 10 Value-chain-based sizing & forecasting
Figure 11 QFD modeling for market share assessment
Figure 12 Market formulation & validation
Figure 13 Network Point-of-Care Glucose Testing Market: Market Outlook (USD Mn), 2020
Figure 14 Shift in POC molecular diagnostic trends
Figure 15 Schematic representation of POC testing device connectivity
Figure 16 Porter’s five forces analysis
Figure 17 SWOT analysis, by factor (political & legal, economic and technological)
Figure 18 Network point-of-care glucose testing market: Product movement analysis
Figure 19 Network Point-of-care glucose testing market: Product outlook and key takeaways
Figure 20 i-STAT market estimates and forecast, 2016 - 2028
Figure 21 Accu-Chek Inform II market estimates and forecast, 2016 - 2028
Figure 22 StatStrip market estimates and forecast, 2016 - 2028
Figure 23 HemoCue market estimates and forecast, 2016 - 2028
Figure 24 CareSens Expert Plus market estimates and forecast, 2016 - 2028
Figure 25 BAROzen H Expert Plus market estimates and forecast, 2016 - 2028
Figure 26 Network global point-of-care glucose testing market: Regional movement analysis
Figure 27 North America network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Figure 28 U.S. network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Figure 29 Canada network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Figure 30 Europe network point-of-care) glucose testing market, 2016 - 2028 (USD Million)
Figure 31 U.K. network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Figure 32 Germany network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Figure 33 France network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Figure 34 Italy network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Figure 35 Spain network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Figure 36 Russia network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Figure 37 Asia Pacific network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Figure 38 Japan network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Figure 39 China network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Figure 40 India network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Figure 41 Australia network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Figure 42 South Korea network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Figure 43 Thailand network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Figure 44 Latin America network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Figure 45 Brazil network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Figure 46 Mexico network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Figure 47 Argentina network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Figure 48 Colombia network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Figure 49 MEA network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Figure 50 South Africa network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Figure 51 Saudi Arabia network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Note: Product cover images may vary from those shown
  • F. Hoffmann-La Roche Ltd.
  • Abbott
  • Nova Biomedical
  • Bayer AG/Ascensia Diabetes Care Holdings AG
  • Danaher
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll